Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
BGR GOVERNMENT AFFAIRS for CHARLES RIVER LABORATORIES
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $90,000.00 income
Pharmacy, Animals
View →
Q1
KLEIN/JOHNSON GROUP for CVS HEALTH
1st Quarter (Jan 1 - Mar 31) 2025 · Rhode Island · House · Senate · $50,000.00 income
Labor Issues/Antitrust/Workplace, Pharmacy, Consumer Issues/Safety/Products
View →
Q1
FARRAGUT PARTNERS LLP for ONEONCOLOGY INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
FARRAGUT PARTNERS LLP for COMMUNITY ONCOLOGY ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q1
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate
Pharmacy, Medicare/Medicaid, Budget/Appropriations
View →
Q1
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q1
BGR GOVERNMENT AFFAIRS for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
BALLARD SPAHR LLP for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for NEUROCRINE BIOSCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
AKIN GUMP STRAUSS HAUER & FELD for CENTRIENT PHARMACEUTICALS LLC
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income
Pharmacy, Health Issues, Manufacturing, Defense
View →
Q1
INVARIANT LLC for SK AMERICAS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $140,000.00 income
Science/Technology, Pharmacy, Energy/Nuclear, Environment/Superfund
View →
Q1
TODD STRATEGY GROUP for GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
CHECKMATE GOVERNMENT RELATIONS for GSK
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $30,000.00 income
Health Issues, Pharmacy
View →
Q1
NAVITUS HEALTH SOLUTIONS for NAVITUS HEALTH SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2025 · Wisconsin · House · Senate
Health Issues, Insurance, Pharmacy
View →
RR
FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia
Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
Q1
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $60,000.00 income
Pharmacy
View →
Q1
STACEY BARRACK D/B/A STACEY BARRACK for VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · Senate · $10,000.00 income
Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
TODD STRATEGY GROUP for EMD SERONO INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy, Health Issues
View →
Q1
THE MADISON GROUP for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $45,000.00 income
Health Issues, Pharmacy, Law Enforcement/Crime/Criminal Justice
View →
Q1
HALEON US HOLDINGS LLC for HALEON US HOLDINGS LLC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Consumer Issues/Safety/Products, Copyright/Patent/Trademark, Food Industry (safety, labeling, etc.), Family issues/Abortion/Adoption
View →
Q1
BOCKORNY GROUP, INC. for CVS HEALTH INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
MONUMENT ADVOCACY for ALBERTSONS
1st Quarter (Jan 1 - Mar 31) 2025 · Idaho · House · Senate · $80,000.00 income
Agriculture, Food Industry (safety, labeling, etc.), Pharmacy, Trade (domestic/foreign)
View →
Q1
TODD STRATEGY GROUP for ASTELLAS PHARMA US, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy, Health Issues
View →
Previous Page 64 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem